Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04920253 · ClinicalTrials.gov registry record · NA
Real World Evidence with the Debritom+ TM Novel Micro Water Jet Technology At a Single Wound Center
A NA study of Diabetic Foot Ulcer and Venous Leg Ulcer, sponsored by Medaxis.
- Recruiting
- Registry status
- NA
- Development phase
- 180
- Enrollment target
- 1
- Study location
NCT04920253 is a NA study of Diabetic Foot Ulcer and Venous Leg Ulcer that is actively recruiting participants, run by Medaxis. The registered enrollment target is 180 participants, below the 252-participant average among 67 other Diabetic Foot Ulcer trials with a reported enrollment target (29% lower). The trial reports 1 study location across 1 state.
The verdict
NCT04920253, a NA study of Diabetic Foot Ulcer and Venous Leg Ulcer, is actively recruiting participants, sponsored by Medaxis.
- RECRUITING
- Registry status
- NA
- Development phase
- 180 participants
- Enrollment target
- 1
- Study location
Study Summary
Prospective, single-blinded, single-center, parallel group, randomized controlled trial (RCT) to assess rate and frequency of wound healing and associated financial savings, when using Medaxis debritom+ versus standard of care as a choice of debridement method, where both arms follow normal wound care practice in use of advanced wound care treatments.
Conditions Studied
Interventions
- DEVICE Study Device Debridement
- DEVICE SOC Debridement
Study Locations (1)
Florida
- MCR Health, Inc. - Bradenton
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 180 participants |
| Start Date | 2021-11-29 |
| Est. Completion | 2025-12 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04920253
The ClinicalTrials.gov registry entry for NCT04920253 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 180 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 252-participant average among 67 other Diabetic Foot Ulcer trials with a reported enrollment target (29% lower). The listed sponsor is Medaxis, which has 2 total studies on file at ClinicalTrials.gov.
The record links to 4 conditions, with Diabetic Foot Ulcer appearing as the primary indexed condition, and to 2 interventions - of which Study Device Debridement is the first listed.
NCT04920253 reports 1 study location spanning 1 distinct geographic area - top geographies include Florida.
Frequently Asked Questions
What is clinical trial NCT04920253 about?
NCT04920253 is a clinical study titled "Real World Evidence with the Debritom+ TM Novel Micro Water Jet Technology At a Single Wound Center". Prospective, single-blinded, single-center, parallel group, randomized controlled trial (RCT) to assess rate and frequency of wound healing and associated financial savings, when using Medaxis debritom+ versus standard of care as a choice of debridement method, where both arms follow normal wound ca...
What is the current status of trial NCT04920253?
This trial is currently recruiting. It is a NA study. The enrollment target is 180 participants. The study started on 2021-11-29. Estimated completion is 2025-12.
What conditions does trial NCT04920253 study?
This clinical trial studies the following conditions: Diabetic Foot Ulcer, Venous Leg Ulcer, Surgical Wound Dehiscence, Traumatic Wounds.
What interventions are being tested in trial NCT04920253?
The interventions under investigation include: Study Device Debridement (DEVICE), SOC Debridement (DEVICE).
Who is sponsoring clinical trial NCT04920253?
This trial is sponsored by Medaxis, which has 2 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04920253 being conducted?
This trial has 1 study location across Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Diabetic Foot Ulcer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Feasibility and Effectiveness of a Remote Monitoring Program for the Treatment of Diabetic Foot Ulcers
RECRUITING · NA
-
Study Assessing Complete Wound Healing by Comparing Surgenex® PelloGraft in Treating DFU and SanoGraft® in Treating VLU to SOC
RECRUITING · NA
-
A Clinical Investigation to Follow the Progress of Exuding Chronic Wounds Using Mepilex® Up as the Primary Dressing.
RECRUITING · NA
-
Modified Platform Trial Evaluating PpLHACM and SOC Versus SOC Alone in the Treatment of Nonhealing DFUs
RECRUITING · NA
-
Derm-Maxx in Patients With Diabetic Foot Ulcers Unresponsive to Standard of Care Treatment Alone
RECRUITING · NA
-
Exercise Enhances Wound Healing in Patients With Diabetic Foot Ulcers
RECRUITING · NA
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.